Cancer diagnosis marker extraction for soft tissue sarcomas based on gene expression profiling data by using projective adaptive resonance theory (PART) filtering method

BMC Bioinformatics

Volumn 7, Issue , 2006, Pages

  Takahashi, Hiro ^a,b,c   Nemoto, Takeshi ^c   Yoshida, Teruhiko ^c   Honda, Hiroyuki ^a   Hasegawa, Tadashi ^c,d  

^a NAGOYA UNIVERSITY   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE RESONANCE THEORY; BIOLOGICAL CHARACTERISTIC; CORRELATION ANALYSIS; DNA MICROARRAY ANALYSIS; GENE EXPRESSION PROFILES; GENE EXPRESSION PROFILING; SIGNIFICANCE ANALYSIS OF MICROARRAYS; THERAPEUTIC TARGETS;

CORRELATION METHODS; DIAGNOSIS; GENE EXPRESSION; MICROARRAYS; TUMORS;

TISSUE ENGINEERING;

DNA; HEAT SHOCK PROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; ONCOPROTEIN; REGULATOR PROTEIN; RGS PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR MARKER;

ARTICLE; CLINICAL ARTICLE; CLUSTER ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE TECHNOLOGY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFORMATION PROCESSING; MARKER GENE; MEDICAL DECISION MAKING; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PROGNOSIS; SIGNAL NOISE RATIO; SOFT TISSUE SARCOMA; UNINDEXED SEQUENCE; ALGORITHM; BIOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROCEDURES; REPRODUCIBILITY; SARCOMA; SOFT TISSUE NEOPLASMS; STATISTICAL MODEL; TUMOR CELL LINE;

ALGORITHMS; CELL LINE, TUMOR; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, STATISTICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; SARCOMA; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33748767667     PISSN: 14712105     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-7-399     Document Type: Article

References (47)

1. Kebriaei P, Anastasi J, Larson RA: Acute lymphoblastic leukaemia: diagnosis and classification. Best Pract Res Clin Haematol 2002, 15(4):597-621.
2. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998, 95(25):14863-14868.
3. Tomida S, Hanai T, Honda H, Kobayashi T: Analysis of expression profile using fuzzy adaptive resonance theory. Bioinformatics 2002, 18(8):1073-1083.
4. Brown MPS, Grundy WN, Lin D, Cristianini N,Sugnet CW, Furey TS, Ares MJ, Haussler D: Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci USA 2000, 97(1):262-267.
5. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286(5439):531-537.
6. Guyon I, Weston J, Barnhill S, Vapnik V: Gene selection for cancer classification using support vector machines. Mach Learning 2002, 46:389-422.
7. Ando T, Suguro M, Hanai T, Kobayashi T, Honda H, Seto M: Fuzzy neural network applied to gene expression profiling for predicting the prognosis of diffuse large B-cell lymphoma. Jpn J Cancer Res 2002, 93(11):1207-1212.
8. Takahashi H, Honda H: A new reliable cancer diagnosis method using boosted fuzzy classifier with a SWEEP operator method. J Chem 2005, 38(9):763-773.
9. Takahashi H, Honda H: Prediction of peptide binding to major histocompatibility complex class II molecules through use of boosted fuzzy classifier with SWEEP operator method. J Biosci Bioeng 2006, 101(2):137-141.
10. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001, 98(9):5116-5121.
11. Tibshirani R, Hastie T, Narasimhan B, Chu G: Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 2002, 99(10):6567-6572.
12. Takahashi H, Kobayashi T, Honda H: Construction of robust prognostic predictors by using projective adaptive resonance theory as a gene filtering method. Bioinformatics 2005, 21(2):179-186.
13. Cao Y, Wu J: Projective ART for clustering data sets in high dimensional spaces. Neural Netw 2002, 15(1):105-120.
14. Cao Y, Wu J: Dynamics of projective adaptive resonance theory model: the foundation of PART algorithm. IEEE Trans Neural Netw 2004, 15(2):245-260.
15. Takahashi H, Honda H: Lymphoma prognostication from expression profiling using a combination method of boosting and projective adaptive resonance theory. J Chem EngJpn 2006, 39(7):767-771.
16. Takahashi H, Aoyagi K, Nakanishi Y, Sasaki H, Yoshida T, Honda H: Classification of intramural metastases and lymph node metastases of esophageal cancer from gene expression based on boosting and projective adaptive resonance theory. JBiosci Bioeng 2006, 102(1):46-52.
17. Sun B, Nishihira J, Yoshiki T, Kondo M, Sato Y, Sasaki F, Todo S: Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway. Clin Cancer Res 2005, 11(3):1050-1058.
18. Ceballos E, Munoz-Alonso MJ, Berwanger B, Acosta JC, Hernandez R, Krause M, Hartmann O, Eilers M, Leon J: Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes. Oncogene 2005, 24(28):4559-4571.
19. Man TK, Lu XY, Jaeweon K, Perlaky L, Harris CP, Shah S, Ladanyi M, Gorlick R, Lau CC, Rao PH: Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer 2004, 4:45.
20. Urano N, Fujiwara Y, Doki Y, Kim SJ, Miyoshi Y, Noguchi S, Miyata H, Takiguchi S, Yasuda T, Yano M, Monden M: Clinical significance of class III beta-tubulin expression and its predictive value for resistance to docetaxel-based chemotherapy in gastric cancer. Int J Oncol 2006, 28(2):375-381.
21. Darnton SJ, Hardie LJ, Muc RS, Wild CP, Casson AG: Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma: loss of expression correlates with poor prognosis. Int J Cancer 2005, 115(3):351-358.
22. Chi JT, Wang Z, Nuyten DS, Rodriguez EH, Schaner ME, Salim A, Wang Y, Kristensen GB, Helland A, Borresen-Dale AL, Giaccia A, Longaker MT, Hastie T, Yang GP, Vijver MJ, Brown PO: Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med 2006, 3(3):e47.
23. Chuang TH, Xu X, Kaartinen V, Heisterkamp N, Groffen J, Bokoch GM: Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein family. Proc Natl Acad Sci USA 1995, 92(22):10282-10286.
24. Tatenhorst L, Senner V, Puttmann S, Paulus W: Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility. J Neuropathol Exp Neurol 2004, 63(3):210-222.
25. van den Boom J, Wolter M, Kuick R, Misek DE, Youkilis AS, Wechsler DS, Sommer C, Reifenberger G, Hanash SM: Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction. Am J Pathol 2003, 163(3):1033-1043.
26. Fischer H, Salahshor S, Stenling R, Bjork J, Lindmark G, Iselius L, Rubio C, Lindblom A: COLI I A I in FAP polyps and in sporadic colorectal tumors. BMC Cancer 2001, 1:17.
27. Ellison DW, Onilude OE, Lindsey JC, Lusher ME, Weston CL, Taylor RE, Pearson AD, Clifford SC: beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's' Cancer Study Group Brain Tumour Committee. J Clin Oncol 2005, 23(31):7951-7957.
28. Dubrovska A, Kanamoto T, Lomnytska M, Heldin CH, Volodko N, Souchelnytskyi S: TGFbetaI/Smad3 counteracts BRCA1-dependent repair of DNA damage. - Oncogene 2005, 24(14):2289-2297.
29. Megonigal MD, Cheung NK, Rappaport EF, Nowell PC, Wilson RB, Jones DH, Addya K, Leonard DG, Kushner BH, Williams TM, Lange BJ, Felix CA: Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors. Proc Natl Acad Sci USA 2000, 97(6):2814-2819.
30. Barille S, Thabard W, Robillard N, Moreau P, Pineau D, Harousseau JL, Bataille R, Amiot M: CD130 rather than CD126 expression is associated with disease activity in multiple myeloma. Br J Haematol 1999, 106(2):532-535.
31. Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Creme E, Wurtz A, Porte H, Huet G: Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent. Cancer 2005, 103(8):1676-1684.
32. Gu ZD, Li JY, Li M, Gu J, Shi XT, Ke Y, Chen KN: Matrix metallo-proteinases expression correlates with survival in patients with esophageal squamous cell carcinoma. Am J Gastroenterol 2005, 100(8):1835-1843.
33. Soni S, Mathur M, Shukla NK, Deo SV, Ralhan R: Stromelysin-3 expression is an early event in human oral tumorigenesis. Int J Cancer 2003, 107(2):309-316.
34. Muller S, van den Boom D, Zirkel D, Koster H, Berthold F, Schwab M, Westphal M, Zumkeller W: Retention of imprinting of the human apoptosis-related gene TSSC3 in human brain tumors. Hum Mol Genet 2000, 9(5):757-763.
35. Ciocca DR, Calderwood SK: Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005, 10(2):86-103.
36. Yamagishi N, Saito Y, Ishihara K, Hatayama T: Enhancement of oxidative stress-induced apoptosis by Hsp 105alpha in mouse embryonal F9 cells. Eur J Biochem 2002, 269(16):4143-4151.
37. Melero I, Gabari I, Corbi AL, Relloso M, Mazzolini G, Schmitz V, Rodriguez-Calvillo M, Tirapu I, Camafeita E, Albar JP, Prieto J: An anti-ICAM-2 (CD102) monoclonal antibody induces immune-mediated regressions of transplanted ICAM-2-negative colon carcinomas. Cancer Res 2002, 62(11):3167-3174.
38. Lee SM, Li ML, Tse YC, Leung SC, Lee MM, Tsui SK, Fung KP, Lee CY, Waye MM: Paeoniae Radix, a Chinese herbal extract, inhibit hepatoma cells growth by inducing apoptosis in a p53 independent pathway. Life Sci 2002, 71(19):2267-2277.
39. Kirikoshi H, Katoh M: Expression of WNT7A in human normal tissues and cancer, and regulation of WNT7A and WNT7B in human cancer. Int J Oncol 2002, 21(4):895-900.
40. Dales JP, Garcia S, Carpentier S, Andrac L, Ramuz O, Lavaut MN, Allasia C, Bonnier P, Charpin C: Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD 105, and CD31 immunocytochemical expression. Hum Pathol 2004, 35(2):176-183.
41. Bhasin M, Raghava GP: SVM based method for predicting HLA-DRB1*0401 binding peptides in an antigen sequence. Bioinformatics 2004, 20(3):421-423.
42. Noguchi H, Hanai T, Takahashi W, Ichii T, Tanikawa M, Masuoka S, Honda H, Kobayashi T: Model construction for quality of beer and brewing process using FNN. (in Japanese). Kagaku Kogaku Ronbunshu 1999, 25::695-701.
43. Noguchi H, Hanai T, Honda H, Harrison LC, Kobayashi T: Fuzzy neural network-based prediction of the motif for MHC class II binding peptides. J Biosci Bioeng 2001, 92(3):227-231.
44. Horikawa S, Furuhashi T, Uchikawa Y: On fuzzy modeling using fuzzy neural networks with the back-propagation algorithm. IEEE T Neurol Networ 1992, 3(5):801-806.
45. Vapnik VN, Chervonenkis A: A note on one class of perceptrons. Automat Rem Control 1964, 25:821-837.
46. Joachims T: Making large-scale SVM learning practical. In Advances in Kernel Methods - Support Vector Learning Edited by: Scholkopf B, Burges C, Smola A. Cambridge, MIT Press; 1999.
47. Freund Y, Schapire RE: A decision-theoretic generalization of online learning and an application to boosting. J Comput System Sci 1997, 55:119-139.